SCAI Meeting In Brief
This article was originally published in The Gray Sheet
Executive Summary
Mitral valve repair: Cardiac Dimensions' Carillon mitral contour system for percutaneous mitral valve repair in patients with functional mitral regurgitation (FMR) met its safety and efficacy endpoints in a small feasibility study presented May 7 at the Society for Cardiovascular Angiography and Interventions annual scientific sessions in Las Vegas. FMR occurs in patients with enlarged hearts whose valve leaflets do not close properly, allowing blood to flow backwards from the left ventricle to the left atrium. According to six-month data from the 30-patient Carillon Mitral Annuloplasty Device European Union Study (AMADEUS), Carillon reduced FMR in patients with moderate-to-severe heart failure, with few major adverse events observed. The device is delivered through a catheter in the jugular vein, positioned around the valve and tightened to facilitate proper closing of the valve leaflets. A pivotal trial could be launched within the year, researchers announced. Carillon received a CE mark in Europe in January